Arvinas (ARVN) Change in Accured Expenses (2017 - 2026)

Arvinas (ARVN) recorded quarterly Change in Accured Expenses of -$6.8 million in Q1 2026, down 142.5% quarter-over-quarter from $16.0 million in Q4 2025, and down 750.0% on a YoY basis from $1.0 million in Q1 2025.

Arvinas (ARVN) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Arvinas' Change in Accured Expenses history runs 10 years deep, the most recent figure standing at -$6.8 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses fell 750.0% year-over-year to -$6.8 million; the TTM figure through Mar 2026 stood at -$7.7 million (down 22.22% YoY), while the FY2025 annual figure was -$1.7 million, up 91.98% from the prior year.
  • Change in Accured Expenses was -$6.8 million for Q1 2026 at Arvinas, down from $16.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $25.2 million in Q4 2022 to a low of -$16.8 million in Q2 2025.
  • Historically, Change in Accured Expenses has averaged $458823.5 across 5 years, with a median of -$100000.0 in 2025.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses surged 3750.0% in 2022, then slumped 1033.33% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $25.2 million in 2022, then sank by 94.84% to $1.3 million in 2023, then plunged by 476.92% to -$4.9 million in 2024, then soared by 426.53% to $16.0 million in 2025, then plunged by 142.5% to -$6.8 million in 2026.
  • The last three Change in Accured Expenses figures came in at -$6.8 million (Q1 2026), $16.0 million (Q4 2025), and -$100000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 931,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 70.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -6.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -6.80 Mn
Mar 31, 2026 -6.80 Mn
Dec 31, 2025 16.00 Mn
Dec 31, 2025 16.00 Mn
Sep 30, 2025 -100,000.00
Sep 30, 2025 -100,000.00
Jun 30, 2025 -16.80 Mn
Jun 30, 2025 -16.80 Mn
Mar 31, 2025 -800,000.00
Mar 31, 2025 -800,000.00
Dec 31, 2024 -4.90 Mn
Dec 31, 2024 -4.90 Mn
Sep 30, 2024 -2.40 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 1.80 Mn
Jun 30, 2024 1.80 Mn
Mar 31, 2024 -15.70 Mn
Mar 31, 2024 -15.70 Mn
Dec 31, 2023 1.30 Mn
Dec 31, 2023 1.30 Mn